PPARα and PPARδ activators inhibit cytokine-induced nuclear translocation of NF-κB and expression of VCAM-1 in EAhy926 endothelial cells

European Journal of Pharmacology

Volumn 435, Issue 2-3, 2002, Pages 143-151

  Rival, Yves ^a   Benéteau, Nathalie ^a   Taillandier, Thierry ^a   Pezet, Mylène ^a   Dupont Passelaigue, Elisabeth ^a   Patoiseau, Jean François ^a   Junquéro, Didier ^a   Colpaert, Francis C ^a   Delhon, André ^a  

^a INSTITUT DE RECHERCHE PIERRE FABRE   (France)

Author keywords

Atherosclerosis; EAhy926 cell; Inflammation; NF B (nuclear factor B); PPAR (peroxisome proliferator activated receptor)

Indexed keywords

15 DEOXY DELTA12,14 PROSTAGLANDIN J2; 4 [4 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY)PROPOXY]PHENOXY]ACETIC ACID; FENOFIBRATE; FENOFIBRIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR AGONIST; PIRINIXIC ACID; PROTEIN SUBUNIT; ROSIGLITAZONE; SYNAPTOTAGMIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1; ACETIC ACID DERIVATIVE; CELL RECEPTOR; CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; PEROXISOME PROLIFERATOR; PHENOL DERIVATIVE; PYRIMIDINE DERIVATIVE; TRANSCRIPTION FACTOR;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL ACTIVATION; CELL ADHESION; CELL VIABILITY; CONTROLLED STUDY; DRUG EFFECT; DRUG POTENCY; ENDOTHELIUM CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; ACTIVE TRANSPORT; BINDING SITE; BIOSYNTHESIS; CELL CULTURE; CELL NUCLEUS; DOWN REGULATION; GENE EXPRESSION; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIUM;

ACETIC ACIDS; ACTIVE TRANSPORT, CELL NUCLEUS; BINDING SITES; CELL NUCLEUS; CELLS, CULTURED; CHEMOKINE CCL2; CYTOKINES; DOWN-REGULATION; ENDOTHELIUM, VASCULAR; GENE EXPRESSION; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MONOCYTES; NF-KAPPA B; PEROXISOME PROLIFERATORS; PHENOLS; PYRIMIDINES; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0037168869     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(01)01589-8     Document Type: Article

References (35)

1. In vitro model of angiogenesis using a human endothelium-derived permanent cell line: Contributions of induced gene expression, G-proteins, and integrins
2. Leukocyte adhesion molecules
3. Endothelial cells in physiology and in the pathophysiology of vascular disorders
4. Biology of disease endothelial nuclear factor-κB and the initiation of the atherosclerotic lesions
5. Transcriptional regulation of endothelial cell adhesion molecules: NF-κB and cytokine-inducible enhancers
6. Peroxisome proliferator-activated receptor activators inhibit thrombin-induced endothelin-1 production in human vascular endothelial cells by inhibiting the activator protein-1 signaling pathway
7. Peroxisome proliferator-activated receptors: Nuclear control of metabolism
8. Permanent cell line expressing human factor VIII-related antigen established by hybridization
9. Ligands for peroxisome proliferator-activated receptor inhibit CCR2 expression stimulated by plasma lipoproteins
10. Peroxisome proliferator-activated receptor δ (PPARδ)-mediated regulation of preadipocyte proliferation and gene expression is dependent on cAMP signaling
11. Expression of peroxisome proliferator-activated receptor α (PPARα) in primary cultures of human vascular endothelial cells
12. Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction
13. Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1 directed migration of monocytes
14. Role for peroxisome proliferator-activated receptor alpha in oxidized phospholipid-induced synthesis of monocyte chemotactic protein-1 and interleukin-8 by endothelial cells
15. Peroxisome proliferator-activated receptor gamma ligands inhibit development of atherosclerosis in LDL receptor-deficient mice
16. PPARα activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells
17. PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease
18. Peroxisome proliferator-activated receptor-gamma activator inhibit IFN-gamma-induced expression of the T cell-active CXC chemokines IP-10, Mig, and I-TAC in human endothelial cells
19. The role of PPAR-γ in macrophage differentiation and cholesterol uptake
20. Monocyte chemoattractant protein-1 in human atheromatous plaques
21. A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transport
22. IL-1β-induced monocyte chemoattractant protein-1 gene expression in endothelial cells is blocked by proteasome inhibitors
23. Modulation of vascular inflammation in vitro and in vivo by peroxisome proliferator-activated receptor-γ activators
24. Anti-inflammatory cyclopentenone prostaglandins are direct inhibitors of IκB kinase
25. The pathogenesis of atherosclerosis: A perspective for the 1990s
26. Monocyte chemotactic and activating factor gene expression induced in endothelial cells by IL-1 and tumor necrosis factor
27. 2 inhibits multiple steps in the NF-κB signaling pathway
28. Detection of monocyte chemoattractant protein-1 in human atherosclerotic lesions by an anti-monocyte chemoattractant protein-1 monoclonal antibody
29. Leucocyte endothelial cell adhesion: A study comparing human umbilical vein endothelial cells and the endothelial cell line EA-hy-926
30. Antioxidants inhibit monocyte adhesion by suppressing nuclear factor-κB mobilization and induction of vascular cell adhesion molecule-1 in endothelial cells stimulated to generate radicals
31. Docosahexaenoic acid selectively attenuates induction of vascular cell adhesion molecule-1 and subsequent monocytic cell adhesion to human endothelial cells stimulated by tumor necrosis factor-α
32. Cyclopentenone prostaglandins - New allies in the war on inflammation
33. The PPARs: From orphan receptors to drug discovery
34. Peroxisome proliferator-activated receptor γ ligands are potent inhibitors of angiogenesis in vitro and in vivo
35. Molecular recognition of fatty acids by peroxisome proliferator-activated receptors